Alzheimer Disease Heterogeneity Explained by Polygenic Risk Scores Derived from Brain Transcriptomic Profiles
Jaeyoon Chung, Nathan J Sahelijo, Toru Maruyama…·Gyungah Jun
This study uses polygenic risk scores derived from brain transcriptomic profiles to explain clinical heterogeneity in Alzheimer's disease.